{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T08:55:40Z","timestamp":1776934540054,"version":"3.51.2"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-026-01505-y","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T08:13:47Z","timestamp":1776932027000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of incidence and outcomes of transformed nodular lymphocyte predominant Hodgkin Lymphoma in the United States: a population-based cohort study"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8122-3852","authenticated-orcid":false,"given":"John L.","family":"Vaughn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malak","family":"Munir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Cobb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sravani","family":"Rimmalapudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8216-3457","authenticated-orcid":false,"given":"Narendranath","family":"Epperla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"1505_CR1","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/S0140-6736(12)60035-X","volume":"380","author":"W Townsend","year":"2012","unstructured":"Townsend W, Linch D. Hodgkin\u2019s lymphoma in adults. Lancet. 2012;380:836\u201347.","journal-title":"Lancet"},{"key":"1505_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01194-5","volume":"14","author":"JL Vaughn","year":"2024","unstructured":"Vaughn JL, Ramdhanny A, Munir M, Rimmalapudi S, Epperla N. A comparative analysis of transformed indolent lymphomas and de novo diffuse large B-cell lymphoma: a population-based cohort study. Blood Cancer J. 2024;14:212.","journal-title":"Blood Cancer J"},{"key":"1505_CR3","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1080\/1042819031000149421","volume":"45","author":"JZ Huang","year":"2004","unstructured":"Huang JZ, Weisenburger DD, Vose JM, Greiner TC, Aoun P, Chan WC, et al. Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group. Leuk Lymphoma. 2004;45:1551\u20137.","journal-title":"Leuk Lymphoma"},{"key":"1505_CR4","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/cncr.24819","volume":"116","author":"I Biasoli","year":"2010","unstructured":"Biasoli I, Stamatoullas A, Meignin V, Delmer A, Reman O, Morschhauser F, et al. Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group. Cancer. 2010;116:631\u20139.","journal-title":"Cancer"},{"key":"1505_CR5","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1200\/JCO.2009.24.9516","volume":"28","author":"M Al-Mansour","year":"2010","unstructured":"Al-Mansour M, Connors JM, Gascoyne RD, Skinnider B, Savage KJ. Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin\u2019s lymphoma. J Clin Oncol. 2010;28:793\u20139.","journal-title":"J Clin Oncol"},{"key":"1505_CR6","doi-asserted-by":"publisher","first-page":"E103","DOI":"10.1002\/ajh.23989","volume":"90","author":"TA Eyre","year":"2015","unstructured":"Eyre TA, Gatter K, Collins GP, Hall GW, Watson C, Hatton CS. Incidence, management, and outcome of high-grade transformation of nodular lymphocyte predominant Hodgkin lymphoma: long-term outcomes from a 30-year experience. Am J Hematol. 2015;90:E103\u201310.","journal-title":"Am J Hematol"},{"key":"1505_CR7","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1182\/blood-2015-08-665505","volume":"127","author":"SS Kenderian","year":"2016","unstructured":"Kenderian SS, Habermann TM, Macon WR, Ristow KM, Ansell SM, Colgan JP, et al. Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution. Blood. 2016;127:1960\u20136.","journal-title":"Blood"},{"key":"1505_CR8","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1182\/blood.2019003877","volume":"135","author":"MS Binkley","year":"2020","unstructured":"Binkley MS, Rauf MS, Milgrom SA, Pinnix CC, Tsang R, Dickinson M, et al. Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG. Blood. 2020;135:2365\u201374.","journal-title":"Blood"},{"key":"1505_CR9","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1200\/JCO.23.01655","volume":"42","author":"MS Binkley","year":"2024","unstructured":"Binkley MS, Flerlage JE, Savage KJ, Akhtar S, Steiner R, Zhang XY, et al. International prognostic score for nodular lymphocyte-predominant Hodgkin Lymphoma. J Clin Oncol. 2024;42:2271\u201380.","journal-title":"J Clin Oncol"},{"key":"1505_CR10","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1182\/bloodadvances.2024013499","volume":"8","author":"JA Florindez","year":"2024","unstructured":"Florindez JA, Chihara D, Reis IM, Lossos IS, Alderuccio JP. Risk of transformation by frontline management in follicular and marginal zone lymphomas: a US population-based analysis. Blood Adv. 2024;8:4423\u201332.","journal-title":"Blood Adv"},{"key":"1505_CR11","doi-asserted-by":"publisher","first-page":"5939","DOI":"10.1182\/bloodadvances.2024013188","volume":"8","author":"C Bommier","year":"2024","unstructured":"Bommier C, Link BK, Gysbers BJ, Maurer MJ, Larson MC, Khurana A, et al. Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature. Blood Adv. 2024;8:5939\u201348.","journal-title":"Blood Adv"},{"key":"1505_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-025-01424-4","volume":"15","author":"M Munir","year":"2025","unstructured":"Munir M, Vaughn JL, Rimmalapudi S, Epperla N. Site-specific prognosis and temporal trends in extranodal marginal zone lymphoma patients in the United States. Blood Cancer J. 2025;15:201.","journal-title":"Blood Cancer J"},{"key":"1505_CR13","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.3324\/haematol.2021.278427","volume":"106","author":"L Paschold","year":"2021","unstructured":"Paschold L, Willscher E, Bein J, Vornanen M, Eichenauer DA, Simnica D, et al. Evolutionary clonal trajectories in nodular lymphocyte-predominant Hodgkin lymphoma with high risk of transformation. Haematologica. 2021;106:2654\u201366.","journal-title":"Haematologica"},{"key":"1505_CR14","doi-asserted-by":"publisher","first-page":"72197","DOI":"10.18632\/oncotarget.12363","volume":"7","author":"B Schuhmacher","year":"2016","unstructured":"Schuhmacher B, Rengstl B, D\u00f6ring C, Bein J, Newrzela S, Brunnberg U, et al. A strong host response and lack of MYC expression are characteristic for diffuse large B cell lymphoma transformed from nodular lymphocyte predominant Hodgkin lymphoma. Oncotarget. 2016;7:72197\u2013210.","journal-title":"Oncotarget"},{"key":"1505_CR15","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1002\/ajh.27459","volume":"99","author":"J Gunawardana","year":"2024","unstructured":"Gunawardana J, Law SC, Sabdia MB, Fennell \u00c9, Hennessy A, Leahy CI, et al. Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma. Am J Hematol. 2024;99:2096\u2013107.","journal-title":"Am J Hematol"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01505-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01505-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01505-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T08:13:48Z","timestamp":1776932028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01505-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1505"],"URL":"https:\/\/doi.org\/10.1038\/s41408-026-01505-y","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"26 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}